Inactivation of ERK1/2 signaling mediates dysfunction of basal meningeal lymphatic vessels in experimental subdural hematoma

Jiangyuan Yuan, Xuanhui Liu, Meng Nie, Yupeng Chen, Mingqi Liu, Jinhao Huang, Weiwei Jiang, Chuang Gao, Wei Quan, Zhitao Gong, Tangtang Xiang, Xinjie Zhang, Zhuang Sha, Chenrui Wu, Dong Wang, Shenghui Li, Jianning Zhang, Rongcai JiangTheranostics 2023 · DOI

Abstract

Meningeal lymphatic vessels (MLVs) are essential for the clearance of subdural hematoma (SDH). However, SDH impairs their drainage function, and the underlying pathogenesis has remained unclear. This study identifies that SDH induces ERK1/2 dephosphorylation in meningeal lymphatic endothelial cells (LECs), leading to disrupted intercellular junctions and vessel dilation. Furthermore, atorvastatin was revealed to protect the structure of basal MLVs and accelerate drainage following SDH by maintaining ERK1/2 signaling.

Introduction: The Brain's Drainage Paradox

A subdural hematoma (SDH) occurs when blood collects between the skull and the brain, typically following head trauma. While surgical intervention is often necessary, the body possesses a natural clearance mechanism: the meningeal lymphatic vessels (MLVs). Basal MLVs, located at the skull base, are particularly efficient at waste removal due to their specialized one-way valves. However, researchers have observed a paradox: the presence of an SDH actually impairs the function of these vessels, hindering the body's ability to heal itself. This study investigates the molecular "off-switch" behind this dysfunction.

Mapping Lymphatic Drainage and Dysfunction

To understand how SDH affects clearance, researchers employed a rat model and tracked the movement of subdural substances using MRI with contrast agents, Evans Blue dye, and fluorescently labeled erythrocytes.

Anatomy of the meningeal lymphatic system and experimental evidence of impaired drainage and structural changes post-SDH.

The results confirmed that basal MLVs are the primary route for clearing blood cells. Following SDH, these vessels exhibit disrupted endothelial junctions and significant lumen dilation, which correlates with impaired drainage into the deep cervical lymph nodes (dCLNs).

The Molecular Mechanism: ERK1/2 Inactivation

Phosphoproteomic analysis of the meninges identified numerous dephosphorylated proteins post-SDH, primarily enriched in the adherens junction pathway. A key finding was the significant dephosphorylation (inactivation) of ERK1/2 within meningeal LECs.

When ERK1/2 signaling is inhibited, the "glue" holding lymphatic cells together—specifically proteins like VE-cadherin—becomes unstable. This structural failure leads to a specific pathology: the vessels do not simply clog; they become leaky and dilated, losing their pumping efficiency.

Quantification of basal MLV diameter showing significant dilation following SDH and after experimental inhibition of ERK1/2.

Therapeutic Potential of Atorvastatin

The study explored whether atorvastatin, a common statin medication, could mitigate these effects. Atorvastatin treatment was found to maintain ERK1/2 activity, thereby preserving the structural integrity of basal MLVs and accelerating the absorption of the hematoma. Crucially, the beneficial effects of atorvastatin were completely abolished when combined with an ERK1/2 inhibitor, confirming that the drug works through this specific signaling pathway to "repair the pipes" of the brain's drainage system.

Conclusion

The impairment of meningeal lymphatic drainage in SDH is driven by the inactivation of ERK1/2 signaling, which destabilizes vessel junctions and causes dilation. Atorvastatin represents a promising pharmacological strategy to restore lymphatic function and improve outcomes for patients with subdural hematomas.

Summary updated

Abstract

<b>Rationale</b>: Meningeal lymphatic vessels (MLVs) are essential for the clearance of subdural hematoma (SDH). However, SDH impairs their drainage function, and the pathogenesis remains unclear. Herein, we aimed to understand the pathological mechanisms of MLV dysfunction following SDH and to test whether atorvastatin, an effective drug for SDH clearance, improves meningeal lymphatic drainage (MLD). <b>Methods</b>: We induced SDH models in rats by injecting autologous blood into the subdural space and evaluated MLD using Gadopentetate D, Evans blue, and CFSE-labeled erythrocytes. Whole-mount immunofluorescence and transmission electron microscopy were utilized to detect the morphology of MLVs. Phosphoproteomics, western blot, flow cytometry, and <i>in vitro</i> experiments were performed to investigate the molecular mechanisms underlying dysfunctional MLVs. <b>Results</b>: The basal MLVs were detected to have abundant valves and play an important role in draining subdural substances. Following SDH, these basal MLVs exhibited disrupted endothelial junctions and dilated lumen, leading to impaired MLD. Subsequent proteomics analysis of the meninges detected numerous dephosphorylated proteins, primarily enriched in the adherens junction, including significant dephosphorylation of ERK1/2 within the meningeal lymphatic endothelial cells (LECs). Subdural injection of the ERK1/2 kinase inhibitor PD98059 resulted in dilated basal MLVs and impaired MLD, resembling the dysfunctional MLVs observed in SDH. Moreover, inhibiting ERK1/2 signaling severely disrupted intercellular junctions between cultured LECs. Finally, atorvastatin was revealed to protect the structure of basal MLVs and accelerate MLD following SDH. However, these beneficial effects of atorvastatin were abolished when combined with PD98059. <b>Conclusion</b>: Our findings demonstrate that SDH induces ERK1/2 dephosphorylation in meningeal LECs, leading to disrupted basal MLVs and impaired MLD. Additionally, we reveal a beneficial effect of atorvastatin in improving MLD.
BibTeX
@inproceedings{yuan2023inactivation,
  author = {Jiangyuan Yuan and Xuanhui Liu and Meng Nie and Yupeng Chen and Mingqi Liu and Jinhao Huang and Weiwei Jiang and Chuang Gao and Wei Quan and Zhitao Gong and Tangtang Xiang and Xinjie Zhang and Zhuang Sha and Chenrui Wu and Dong Wang and Shenghui Li and Jianning Zhang and Rongcai Jiang},
  title = {{Inactivation of ERK1/2 signaling mediates dysfunction of basal meningeal lymphatic vessels in experimental subdural hematoma}},
  booktitle = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.87633},
}
Figure